Compounds > sertraline
Page last updated: 2024-08-24

sertraline and Parkinson Disease, Secondary

sertraline has been researched along with Parkinson Disease, Secondary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benuiwal, RP; Mendhekar, DN; Puri, V1
Cano, A; Roquer, J1
Byerly, MJ; Christensen, RC; Evans, OL1
Leo, RJ1
Nunes, EV; Schechter, DS1
Brannan, T; Di Rocco, A; Prikhojan, A; Yahr, MD1
Pina Latorre, MA; Zabala López, S1
Calvo, M; Catalán, C; Modrego, PJ; Pina Latorre, MA; Rodilla, F1

Reviews

1 review(s) available for sertraline and Parkinson Disease, Secondary

ArticleYear
Movement disorders associated with the serotonin selective reuptake inhibitors.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10

    Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States

1996

Other Studies

7 other study(ies) available for sertraline and Parkinson Disease, Secondary

ArticleYear
Parkinsonism and elevated lactic acid with sertraline.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:5

    Topics: Basal Ganglia; Depressive Disorder, Major; Female; Humans; Lactic Acid; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline

2005
[Parkinsonism secondary to the use of sertraline].
    Medicina clinica, 1995, Dec-08, Volume: 105, Issue:20

    Topics: 1-Naphthylamine; Aged; Antidepressive Agents; Female; Humans; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Delirium associated with a combination of sertraline, haloperidol, and benztropine.
    The American journal of psychiatry, 1996, Volume: 153, Issue:7

    Topics: 1-Naphthylamine; Adult; Benztropine; Delirium; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Reversible parkinsonism in a 90-year-old man taking sertraline.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:6

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism.
    Journal of neural transmission (Vienna, Austria : 1996), 1998, Volume: 105, Issue:2-3

    Topics: 1-Naphthylamine; 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Microdialysis; Neostriatum; Parkinson Disease, Secondary; Rats; Sertraline

1998
[Reversible parkinsonism secondary to the use of sertraline].
    Neurologia (Barcelona, Spain), 1998, Volume: 13, Issue:9

    Topics: Aged; Female; Humans; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Parkinsonism and Parkinson's disease associated with long-term administration of sertraline.
    Journal of clinical pharmacy and therapeutics, 2001, Volume: 26, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Humans; Parkinson Disease, Secondary; Parkinsonian Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline

2001